History and Perspectives
暂无分享,去创建一个
[1] D. Aunis,et al. Characterization of natural vasostatin‐containing peptides in rat heart , 2006, The FEBS journal.
[2] S. Mahata,et al. Pancreastatin is an endogenous peptide that regulates glucose homeostasis. , 2013, Physiological genomics.
[3] D. O'Connor,et al. Processing of chromogranin A by plasmin provides a novel mechanism for regulating catecholamine secretion. , 2000, The Journal of clinical investigation.
[4] Y. Loh,et al. A new chromogranin A-dependent angiogenic switch activated by thrombin. , 2013, Blood.
[5] C. Lanzani,et al. Chromogranin-A production and fragmentation in patients with Takayasu arteritis , 2016, Arthritis Research & Therapy.
[6] Y. Loh,et al. Serpinin: a novel chromogranin A-derived, secreted peptide up-regulates protease nexin-1 expression and granule biogenesis in endocrine cells. , 2011, Molecular endocrinology.
[7] F. Crea,et al. Myocardial production of chromogranin A in human heart: a new regulatory peptide of cardiac function. , 2007, European heart journal.
[8] K. Helle,et al. The vasoinhibitory activity of bovine chromogranin A fragment (vasostatin) and its independence of extracellular calcium in isolated segments of human blood vessels , 1992, Regulatory Peptides.
[9] N. Hillarp,et al. The Isolation of n Granular Fraction from the Suprarenal Medulla, Containing the Symyathomimetic Catechol Amines1 , 1953 .
[10] S. Mahata,et al. Chromogranin A in human disease. , 2000, Advances in experimental medicine and biology.
[11] B. Falck,et al. Content and intracellular distribution of adenosine triphosphate in cow adrenal medulla. , 1956, Acta physiologica Scandinavica.
[12] A. Corti,et al. Full-length human chromogranin-A cardioactivity: myocardial, coronary, and stimulus-induced processing evidence in normotensive and hypertensive male rat hearts. , 2013, Endocrinology.
[13] R. Wetzstein. Elektronenmikroskopische Untersuchungen am Nebennierenmark von Maus, Meerschweinchen und Katze , 2004, Zeitschrift für Zellforschung und Mikroskopische Anatomie.
[14] A. Corti. Chromogranin A and the Tumor Microenvironment , 2010, Cellular and Molecular Neurobiology.
[15] R. Levi,et al. Vasostatin 1 activates eNOS in endothelial cells through a proteoglycan‐dependent mechanism , 2010, Journal of cellular biochemistry.
[16] R. Angeletti,et al. Vasoinhibitory activity of synthetic peptides from the amino terminus of chromogranin A. , 1994, Acta physiologica Scandinavica.
[17] Y. Loh,et al. Chromogranin A: A new proposal for trafficking, processing and induction of granule biogenesis , 2010, Regulatory Peptides.
[18] K. Helle,et al. The chromogranin A peptide vasostatin-I inhibits gap formation and signal transduction mediated by inflammatory agents in cultured bovine pulmonary and coronary arterial endothelial cells , 2006, Regulatory Peptides.
[19] D. Aunis,et al. Intracellular and extracellular processing of chromogranin A. Determination of cleavage sites. , 1993, European journal of biochemistry.
[20] Y. Loh,et al. Serpinins: role in granule biogenesis, inhibition of cell death and cardiac function. , 2012, Current medicinal chemistry.
[21] K. Helle. The chromogranin A-derived peptides vasostatin-I and catestatin as regulatory peptides for cardiovascular functions. , 2010, Cardiovascular research.
[22] D. O'Connor,et al. Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension. , 2002, Journal of hypertension.
[23] Wayne A. Decatur,et al. Is secretoneurin a new hormone? , 2012, General and comparative endocrinology.
[24] U. S. Euler. The Presence of the Adrenergic Nenrotransmitter in Intraaxonal Structures. , 1958 .
[25] K. Helle. Regulatory peptides from chromogranin A and secretogranin II: Putative modulators of cells and tissues involved in inflammatory conditions , 2010, Regulatory Peptides.
[26] A. D. Smith,et al. Secretion of a Chromaffin Granule Protein, Chromogranin, from the Adrenal Gland after Splanchnic Stimulation , 1967, Nature.
[27] R. Longhi,et al. Chromogranin A binds to αvβ6-integrin and promotes wound healing in mice , 2012, Cellular and Molecular Life Sciences.
[28] R. Fischer‐Colbrie,et al. The chromogranins A and B: The first 25 years and future perspectives , 1992, Neuroscience.
[29] K. Helle,et al. Interactions of chromogranin A-derived vasostatins and monolayers of phosphatidylserine, phosphatidylcholine and phosphatidylethanolamine , 2006, Regulatory Peptides.
[30] R. Ferrari,et al. Chromogranin A and Tumor Necrosis Factor-α (TNF) in Chronic Heart Failure , 2002 .
[31] R. Angeletti,et al. Chromogranin A: a multipurpose prohormone? , 1994, Acta physiologica Scandinavica.
[32] G. Greeley,et al. Parastatin (porcine chromogranin A347-419), a novel chromogranin A-derived peptide, inhibits parathyroid cell secretion. , 1993, Endocrinology.
[33] A. D. Smith,et al. Purification and properties of an acidic protein from chromaffin granules of bovine adrenal medulla. , 1967, The Biochemical journal.
[34] K. Helle,et al. A physiological role for the granins as prohormones for homeostatically important regulatory peptides? A working hypothesis for future research. , 2000, Advances in experimental medicine and biology.
[35] R. Angeletti,et al. Determination of residues in chromogranin A-(16-40) required for inhibition of parathyroid hormone secretion. , 1996, Endocrinology.
[36] U. S. Euler,et al. Evidence for the Presence of Noradrenaline in Submicroscopic Structures of Adrenergic Axons , 1956, Nature.
[37] D. O'Connor,et al. Catestatin: A multifunctional peptide from chromogranin A , 2010, Regulatory Peptides.
[38] T. Angelone,et al. The chromogranin A-derived vasostatins: new players in the endocrine heart. , 2008, Current medicinal chemistry.
[39] L. Eiden. Is chromogranin a prohormone? , 1987, Nature.
[40] G. Born,et al. Observations on the distribution of catechol amines and adenosinetriphosphate in the bovine adrenal medulla , 1956, The Journal of physiology.
[41] K. Helle,et al. Chromogranin A-derived peptides: interaction with the rat posterior cerebral artery , 2005, Regulatory Peptides.
[42] R. Kirchmair,et al. Secretoneurin—a neuropeptide generated in brain, adrenal medulla and other endocrine tissues by proteolytic processing of secretogranin II (chromogranin C) , 1993, Neuroscience.
[43] D. Aunis,et al. Structural and Biological Characterization of Chromofungin, the Antifungal Chromogranin A-(47–66)-derived Peptide* , 2001, The Journal of Biological Chemistry.
[44] M. A. Brioso,et al. Functional Role of Chromogranins , 2002 .
[45] V. Sánchez-Margalet,et al. Pancreastatin, a chromogranin A-derived peptide, inhibits DNA and protein synthesis by producing nitric oxide in HTC rat hepatoma cells. , 2001, Journal of hepatology.
[46] D. Aunis,et al. Chromogranins: Current Concepts , 2002 .
[47] Hao Wang,et al. Secretoneurin increases monolayer permeability in human coronary artery endothelial cells. , 2006, Surgery.
[48] W. Huttner,et al. Chromogranin A and pancreastatin , 1987, Nature.
[49] A. Corti,et al. Human recombinant chromogranin A-derived vasostatin-1 mimics preconditioning via an adenosine/nitric oxide signaling mechanism. , 2007, American journal of physiology. Heart and circulatory physiology.
[50] D. Aunis,et al. Antibacterial Peptides Are Present in Chromaffin Cell Secretory Granules , 1998, Cellular and Molecular Neurobiology.
[51] P. Norlén,et al. Chromogranin A and Its Derived Peptides in the Rat and Procine Gastro-Entero-Pancreatic System , 2002 .
[52] V. Mutt,et al. Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion , 1986, Nature.
[54] C. Wiedermann,et al. The neuropeptide secretoneurin stimulates adhesion of human monocytes to arterial and venous endothelial cells in vitro , 2002, Regulatory Peptides.
[55] B. Brar,et al. The antihypertensive chromogranin a peptide catestatin acts as a novel endocrine/paracrine modulator of cardiac inotropism and lusitropism. , 2008, Endocrinology.
[56] G. Heinze,et al. Identification of the Vasoconstriction-Inhibiting Factor (VIF), a Potent Endogenous Cofactor of Angiotensin II Acting on the Angiotensin II Type 2 Receptor , 2015, Circulation.
[57] R. Ferrari,et al. Chromogranin A in heart failure; a novel neurohumoral factor and a predictor for mortality. , 2002, European heart journal.
[58] K. Helle,et al. Two Chromogranin A-Derived Peptides Induce Calcium Entry in Human Neutrophils by Calmodulin-Regulated Calcium Independent Phospholipase A2 , 2009, PloS one.
[59] K. Helle,et al. N-terminal chromogranin-derived peptides as dilators of bovine coronary resistance arteries , 2002, Regulatory Peptides.
[60] D. Aunis,et al. Chromogranin A Induces a Neurotoxic Phenotype in Brain Microglial Cells* , 1998, The Journal of Biological Chemistry.
[61] K. Helle,et al. The endocrine role for chromogranin A: A prohormone for peptides with regulatory properties , 2007, Cellular and Molecular Life Sciences.
[62] D. O'Connor,et al. Chromogranin A in children with neuroblastoma. Serum concentration parallels disease stage and predicts survival. , 1990, The Journal of clinical investigation.
[63] A. Bandyopadhyay,et al. Defining the Role of Integrin αvβ6 in Cancer , 2009 .
[64] E. Robertis,et al. Plurivesicular secretory processes and nerve endings in the pineal gland of the rat. , 1961 .
[65] Ying Yang,et al. Plasma catestatin level in patients with acute myocardial infarction and its correlation with ventricular remodelling , 2012, Postgraduate Medical Journal.
[66] T. Omland,et al. Prognostic value of circulating chromogranin A levels in acute coronary syndromes , 2008, European heart journal.
[67] K. Helle. The granin family of uniquely acidic proteins of the diffuse neuroendocrine system: comparative and functional aspects , 2004, Biological reviews of the Cambridge Philosophical Society.
[68] M. Belting,et al. Heparan sulfate proteoglycan as a cell-surface endocytosis receptor. , 2014, Matrix biology : journal of the International Society for Matrix Biology.
[69] K. Helle. Antibody formation against soluble protein from bovine adrenal chromaffin granules. , 1966, Biochimica et biophysica acta.
[70] A. Corti,et al. Chromogranin A expression in neoplastic cells affects tumor growth and morphogenesis in mouse models. , 2002, Cancer research.
[71] R. Fischer‐Colbrie,et al. Secretoneurin--a novel link between the nervous and the immune system. Conservation of the sequence and functional aspects. , 2000, Advances in experimental medicine and biology.
[72] K. Helle,et al. Evidence for the presence of a chromogranin-like protein in bovine splenic nerve granules. , 1969, Molecular pharmacology.
[73] Y. Loh,et al. Role of pGlu-Serpinin, a Novel Chromogranin A-Derived Peptide in Inhibition of Cell Death , 2011, Journal of Molecular Neuroscience.
[74] L. Toledo-Pereyra,et al. The molecular events underlying ischemia/reperfusion injury. , 2002, Transplantation proceedings.
[75] G. Lip,et al. Endothelial progenitor cells, endothelial dysfunction, inflammation, and oxidative stress in hypertension. , 2008, Antioxidants & redox signaling.
[76] A. Corti,et al. Chromogranin A regulates tumor self-seeding and dissemination. , 2012, Cancer research.
[77] A. Villa,et al. Chromogranin A protects vessels against tumor necrosis factor α‐induced vascular leakage , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[78] N. Cawley,et al. The novel chromogranin A‐derived serpinin and pyroglutaminated serpinin peptides are positive cardiac β‐adrenergic‐like inotropes , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[79] U. S. Euler,et al. A Specific Sympathomimetic Ergone in Adrenergic Nerve Fibres (Sympathin) and its Relations to Adrenaline and Nor-Adrenaline , 1946 .
[80] D. Aunis,et al. Antibacterial and Antifungal Activities of Vasostatin-1, the N-terminal Fragment of Chromogranin A* , 2000, The Journal of Biological Chemistry.
[81] S. Mahata,et al. Catestatin Increases the Expression of Anti-Apoptotic and Pro-Angiogenetic Factors in the Post-Ischemic Hypertrophied Heart of SHR , 2014, PloS one.
[82] D. Aunis,et al. Processing of chromogranin B in bovine adrenal medulla. Identification of secretolytin, the endogenous C-terminal fragment of residues 614-626 with antibacterial activity. , 1995, European journal of biochemistry.
[83] G. Portela-Gomes. Chromogranin A immunoreactivity in neuroendocrine cells in the human gastrointestinal tract and pancreas. , 2000, Advances in experimental medicine and biology.
[84] V. Sánchez-Margalet,et al. Pancreastatin. Biological effects and mechanisms of action. , 2000, Advances in experimental medicine and biology.
[85] V. Sánchez-Margalet,et al. Pancreastatin inhibits insulin action in rat adipocytes. , 1998, The American journal of physiology.
[86] D. Aunis,et al. The antimicrobial peptides derived from chromogranin/secretogranin family, new actors of innate immunity , 2010, Regulatory Peptides.
[87] F C Kafatos,et al. Phylogenetic perspectives in innate immunity. , 1999, Science.
[88] D. O'Connor,et al. Radioimmunoassay of chromogranin A in plasma as a measure of exocytotic sympathoadrenal activity in normal subjects and patients with pheochromocytoma. , 1984, The New England journal of medicine.
[89] S. Roatta,et al. The chromogranin A- derived N-terminal peptide vasostatin-I: In vivo effects on cardiovascular variables in the rabbit , 2011, Regulatory Peptides.
[90] N. Hillarp. Further observations on the state of the catechol amines stored in the adrenal medullary granules. , 1960, Acta physiologica Scandinavica.
[91] R. Coupland. Determining Sizes and Distribution of Sizes of Spherical Bodies such as Chromaffin Granules in Tissue Sections , 1968, Nature.
[92] S. Gorr,et al. Autocrine regulation of parathyroid secretion: inhibition of secretion by chromogranin-A (secretory protein-I) and potentiation of secretion by chromogranin-A and pancreastatin antibodies. , 1990, Endocrinology.
[93] K. Helle,et al. Vasostatins, Comprising the N‐terminal Domain of Chromogranin A, Suppress Tension in Isolated Human Blood Vessel Segments , 1993, Journal of neuroendocrinology.
[94] D. O'Connor,et al. Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist. , 1997, The Journal of clinical investigation.
[95] R. Angeletti,et al. Regulation of Parathyroid Secretion , 2002 .
[96] E. Schäfer,et al. The Physiological Effects of Extracts of the Suprarenal Capsules , 1895, The Journal of physiology.
[97] A. Corti,et al. Chromogranin A and the endothelial barrier function. , 2012, Current medicinal chemistry.
[98] D. Aunis,et al. Antibacterial and Antifungal Peptides Derived from Chromogranins and Proenkephalin-A , 2002 .
[99] K. Helle,et al. Chromogranin A: a paradoxical player in angiogenesis and vascular biology , 2014, Cellular and Molecular Life Sciences.
[100] D. O'Connor,et al. The neuroendocrine peptide catestatin is a cutaneous antimicrobial and induced in the skin after injury. , 2008, The Journal of investigative dermatology.
[101] K. Helle,et al. Vasostatins. Dilators of bovine resistance arteries. , 2000, Advances in experimental medicine and biology.
[102] A. Corti,et al. Vasostatin-I, a chromogranin A-derived peptide, in non-selected critically ill patients: distribution, kinetics, and prognostic significance , 2012, Intensive Care Medicine.
[103] P. Norlén,et al. Chromogranin A and its derived peptides in the rat and porcine gastro-entero-pancreatic system. Expression, localization, and characterization. , 2000, Advances in experimental medicine and biology.
[104] K. Helle,et al. Catestatin (CgA344–364) stimulates rat mast cell release of histamine in a manner comparable to mastoparan and other cationic charged neuropeptides , 2003, Regulatory Peptides.
[105] L. L. Chu,et al. Isolation and partial characterization of secretory protein I from bovine parathyroid glands. , 1981, Biochemistry.
[106] W. Huttner,et al. The primary structure of human chromogranin A and pancreastatin. , 1987, The Journal of biological chemistry.
[107] H. Vaudry,et al. Neuroendocrine cell-specific expression and regulation of the human secretogranin II gene. , 2000, Advances in experimental medicine and biology.
[108] J. Lever. Electron microscopic observations on the normal and denervated adrenal medulla of the rat. , 1955, Endocrinology.
[109] R. Angeletti,et al. Inhibition of parathyroid hormone secretion by amino-terminal chromogranin peptides. , 1994, Endocrinology.
[110] N. Amodio,et al. Chromofungin, CgA47-66-derived peptide, produces basal cardiac effects and postconditioning cardioprotective action during ischemia/reperfusion injury , 2015, Peptides.
[111] D. O'Connor,et al. Regulation of chromogranin A transcription and catecholamine secretion by the neuropeptide PACAP. Stimulation and desensitization. , 2000, Advances in experimental medicine and biology.
[112] H. Gerdes,et al. Signal-mediated sorting of chromogranins to secretory granules. , 2000, Advances in experimental medicine and biology.
[113] N. Kirshner,et al. A specific soluble protein from the catecholamine storage vesicles of bovine adrenal medulla. I. Purification and chemical characterization. , 1967, Molecular pharmacology.
[114] S. Mahata,et al. Catestatin Improves Post-Ischemic Left Ventricular Function and Decreases Ischemia/Reperfusion Injury in Heart , 2010, Cellular and Molecular Neurobiology.
[115] K. Helle,et al. The release of protein from the stimulated adrenal medulla. , 1965, The Biochemical journal.
[116] V. Sánchez-Margalet,et al. Pancreastatin action in the liver: dual coupling to different G proteins. , 1996, Cellular signalling.
[117] D. Aunis,et al. Chromogranin A induces a neurotoxic phenotype in brain microglial cells. , 1998, The Journal of biological chemistry.
[118] K. Helle. Some chemical and physical properties of the soluble protein fraction of bovine adrenal chromaffin granules. , 1966, Molecular pharmacology.
[119] K. Helle,et al. Endothelial handling of chromogranin A. , 2000, Advances in experimental medicine and biology.
[120] K. Helle,et al. The vasostatin‐I fragment of chromogranin A inhibits VEGF‐induced endothelial cell proliferation and migration , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[121] H. Blaschko,et al. Localization of adrenaline in cytoplasmic particles of the bovine adrenal medulla , 2004, Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie.
[122] Chao-shu Tang,et al. Plasma levels and potential roles of catestatin in patients with coronary heart disease , 2013, Scandinavian cardiovascular journal : SCJ.
[123] S. Rong,et al. The Neuropeptide Catestatin Acts As a Novel Angiogenic Cytokine via a Basic Fibroblast Growth Factor–Dependent Mechanism , 2010, Circulation research.
[124] K. Helle,et al. Role of vasostatin-1 C-terminal region in fibroblast cell adhesion , 2010, Cellular and Molecular Life Sciences.
[125] V. Mutt,et al. Pancreastatin and islet hormone release. , 1987, Proceedings of the National Academy of Sciences of the United States of America.